These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 822863)

  • 21. A novel multi-peptide subunit vaccine admixed with AddaVax adjuvant produces significant immunogenicity and protection against Proteus mirabilis urinary tract infection in mice model.
    Choubini E; Habibi M; Khorshidi A; Ghasemi A; Asadi Karam MR; Bouzari S
    Mol Immunol; 2018 Apr; 96():88-97. PubMed ID: 29525454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Local immunization against P. aeruginosa with an outer-membrane-protein vaccine].
    Grundmann T; Freihorst J; Kubesch P; Tümmler B; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):924-7. PubMed ID: 1763004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of active and passive antibacterial immunization on skin allograft survival in rabbits.
    Liska M; Hatala M
    Folia Biol (Praha); 1979; 25(1):70-5. PubMed ID: 107050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.
    Alamuri P; Eaton KA; Himpsl SD; Smith SN; Mobley HL
    Infect Immun; 2009 Feb; 77(2):632-41. PubMed ID: 19029299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis.
    Li X; Erbe JL; Lockatell CV; Johnson DE; Jobling MG; Holmes RK; Mobley HL
    Infect Immun; 2004 Dec; 72(12):7306-10. PubMed ID: 15557656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross protective immunity in mice injected with heat-killed cells of Pseudomonas aeruginosa and Serratia marcescens.
    Homma JY; Ito M; Yabuuchi E
    Jpn J Exp Med; 1972 Dec; 42(6):583-5. PubMed ID: 4634197
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective characteristics of the antigen common to Pseudomonas and Vibrio and significance of bacterial endotoxins in protection against selected bacterial infections.
    Sourek J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):538-47. PubMed ID: 2413656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immunity induced by the vaccination of recombinant Proteus mirabilis OmpA expressed in Pichia pastoris.
    Zhang Y; Yang S; Dai X; Liu L; Jiang X; Shao M; Chi S; Wang C; Yu C; Wei K; Zhu R
    Protein Expr Purif; 2015 Jan; 105():33-8. PubMed ID: 25317910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Protective properties of Proteus ribosomal vaccine].
    Ovetchin PV; Tsyganenko AIa
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):19-23. PubMed ID: 6367317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of novel putative immunogenic targets against Proteus mirabilis using a reverse vaccinology approach.
    Noori Goodarzi N; Bolourchi N; Fereshteh S; Badmasti F
    Infect Genet Evol; 2021 Nov; 95():105045. PubMed ID: 34428568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of vaccination against systemic Serratia infection.
    Kumagai Y; Okada K; Ishimaru T; Sawae Y; Kuroiwa A; Nomoto K
    J Clin Lab Immunol; 1989 Jul; 29(3):125-32. PubMed ID: 2699333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.
    Sorensen RU; Stern RC; Chase P; Polmar SH
    Infect Immun; 1979 Feb; 23(2):398-402. PubMed ID: 106011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An acellular vaccine from Pseudomonas aeruginosa. II. -- Estimate of immuneserum protective effect by measure of bacterial clearance (author's transl)].
    Daoulas-Le Bourdelles F; Berche P; Véron M
    Ann Microbiol (Paris); 1977 Jul; 128B(1):61-71. PubMed ID: 410340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of common protective antigen vaccination to protect mink from challenge exposure with Pseudomonas aeruginosa.
    Shimizu T; Homma JY; Abe C; Tanamoto T; Aoyama Y; Yanagawa R; Fujimoto Y; Noda H; Takashima I; Honda E; Minamide S
    Am J Vet Res; 1976 Dec; 37(12):1441-4. PubMed ID: 826199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of urinary tract infections with SolcoUrovac].
    Litschgi M
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):107-10. PubMed ID: 3106132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The anodically moving thermolabile antigen (ATA) of Gram negative bacteria. Protection of mice by immunization with ATA (author's transl)].
    Seltmann G; Reissbrodt R
    Acta Microbiol Acad Sci Hung; 1979; 26(1):55-62. PubMed ID: 384750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preventive properties of the blood sera from persons vaccinated with a Proteus vaccine made from soluble antigen complexes].
    Levina LA; Kreĭnin LS; Kaverina KG; Zdanovskaia LK; Iurova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):84-8. PubMed ID: 3087123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
    Saha S; Takeshita F; Sasaki S; Matsuda T; Tanaka T; Tozuka M; Takase K; Matsumoto T; Okuda K; Ishii N; Yamaguchi K; Klinman DM; Xin KQ; Okuda K
    Vaccine; 2006 Sep; 24(37-39):6240-9. PubMed ID: 16806598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against hemorrhagic pneumonia of mink by Pseudomonas aeruginosa multicomponent vaccine.
    Aoi Y; Noda H; Yanagawa R; Homma JY; Abe C; Morihara K; Goda A; Takeuchi S; Ishihara T
    Jpn J Exp Med; 1979 Jun; 49(3):199-207. PubMed ID: 114699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.